 | Zai Lab Ltd (NASDAQ:ZLAB) Receives Consensus Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - February 14 at 2:44 AM |
| Zai Lab Ltd (NASDAQ:ZLAB) Short Interest Update
www.americanbankingnews.com - February 13 at 1:22 AM |
 | Zai Lab Announces Upcoming Participation at February Conferences
finance.yahoo.com - February 11 at 8:34 AM |
 | Zai Lab application for omadacycline accepted in China
seekingalpha.com - February 10 at 1:49 PM |
| Zai Lab Announces Acceptance of NDA Submission of Omadacycline in China by the NMPA
finance.yahoo.com - February 10 at 8:48 AM |
| Zai Lab Announces First Patients Treated in Separate Phase 1b and Registrational Bridging Studies
finance.yahoo.com - February 4 at 9:23 AM |
| Zai Lab Announces Closing of Public Offering of American Depositary Shares and Full Exercise of Greenshoe Option
finance.yahoo.com - January 27 at 6:00 PM |
 | Zai Lab (ZLAB) Hits All-time High: Did You Ride The Rally?
www.nasdaq.com - January 26 at 2:10 PM |
| Zai Lab prices $261M ADS offering; shares down 2% premarket
seekingalpha.com - January 23 at 8:31 AM |
| Zai Lab Announces Pricing of Public Offering of American Depositary Shares
finance.yahoo.com - January 22 at 10:29 PM |
| Zai Lab launches equity offering; shares down 1% after hours
seekingalpha.com - January 21 at 9:11 PM |
| Zai Lab Announces Proposed Public Offering of American Depositary Shares
finance.yahoo.com - January 21 at 9:11 PM |
| Zai Lab Appoints Lonnie Moulder to Board of Directors
finance.yahoo.com - January 14 at 8:25 AM |
| Zai Lab and Novocure Announce First Patient Enrolled in a Phase 2 Pilot Trial of Tumor Treating Fields Together with Chemotherapy as First-Line Treatment of Gastric Cancer
finance.yahoo.com - January 9 at 4:33 PM |
| Week In Review: Geneseeq And Elpiscience Close $100 Million VC Rounds; Zai Lab's PARP Inhibitor Approved For China Use
seekingalpha.com - December 31 at 1:22 AM |
| How Does Zai Lab Limited (NASDAQ:ZLAB) Affect Your Portfolio Volatility?
finance.yahoo.com - December 30 at 10:18 AM |
| Zai Lab's NDA for Zeluja for recurrent ovarian cancer OK'd in China
seekingalpha.com - December 27 at 10:30 PM |
| Zai Lab Announces NMPA Approval of ZEJULA® (Niraparib) in China as Maintenance Therapy for Patients with Recurrent Ovarian Cancer
finance.yahoo.com - December 27 at 12:26 PM |
| Benzinga Pro's Top 5 Stocks To Watch For Fri., Dec. 27, 2019: NKE, AXE, PT, FLXN, ZLAB
finance.yahoo.com - December 27 at 12:26 PM |
| Zai Lab Announces Upcoming Presentation at 38th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - December 23 at 8:07 AM |
| Zai Lab Announces the Appointment of Timothy Yap, M.D., Ph.D., to its Scientific Advisory Board
finance.yahoo.com - December 16 at 12:28 PM |
| Hedge Funds Have Never Been This Bullish On Zai Lab Limited (ZLAB)
finance.yahoo.com - December 8 at 11:00 PM |
 | The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
feeds.benzinga.com - December 6 at 8:16 AM |
 | Buy These 2 Stocks to Access China's Huge Healthcare Market
www.fool.com - November 6 at 8:27 AM |
| Five Prime Restructuring Puts It Into A Better Position
seekingalpha.com - October 31 at 6:13 PM |
| Zai Lab Announces Upcoming Presentations at November Conferences
finance.yahoo.com - October 30 at 7:59 AM |
| Zai Lab Partner, MacroGenics, Announces Initiation of Phase 2/3 MAHOGANY Study of Margetuximab in Gastric or Gastroesophageal Junction Cancer
finance.yahoo.com - October 25 at 12:39 PM |
 | Zai Lab Partner, GSK, Announces U.S. Food and Drug Administration Approval of Additional Indication for Zejula (niraparib) for
www.bloomberg.com - October 24 at 8:40 AM |
| Zai Lab Partner, GSK, Announces U.S. Food and Drug Administration Approval of Additional Indication for Zejula (niraparib) for Late-line Treatment for Women with Recurrent Ovarian Cancer
finance.yahoo.com - October 24 at 8:40 AM |
| Dr. Samantha Du, Zai Lab Founder and CEO, to Participate in Forbes Global CEO Conference
finance.yahoo.com - October 4 at 2:34 PM |
 | BRIEF-Zai Lab Announces Phase 3 PRIMA trial of Zejula(niraparib)
www.msn.com - September 29 at 9:37 PM |
| Phase 3 PRIMA trial of Zejula® (niraparib) is the first study to show a PARP inhibitor significantly improves PFS, regardless
www.bloomberg.com - September 29 at 3:49 PM |
| Should Zai Lab (NASDAQ:ZLAB) Be Disappointed With Their 93% Profit?
finance.yahoo.com - September 13 at 9:38 AM |
| Zai Lab Limited (ZLAB) Q2 2019 Earnings Call Transcript
finance.yahoo.com - September 4 at 12:11 PM |
 | Zai Lab out with 1H Numbers
www.baystreet.ca - September 3 at 10:51 AM |
| Zai Lab Ltd. to Host Earnings Call
finance.yahoo.com - September 3 at 10:51 AM |
| Zai Lab Announces Financial Results and Corporate Update for the Six Months Ended June 30, 2019
finance.yahoo.com - September 3 at 10:51 AM |
| BRIEF-Zai Lab Announces Publication Of Pharmacokinetic Study Of Niraparib In Chinese Ovarian Cancer Patients
www.msn.com - August 27 at 10:58 PM |
| Zai Lab Announces Publication of Pharmacokinetic Study of Niraparib in Chinese Ovarian Cancer Patients
finance.yahoo.com - August 27 at 10:19 AM |
| Zai Lab Announces Upcoming Presentations at September Conferences
finance.yahoo.com - August 26 at 10:15 AM |
| Zai Lab to Report Financial Results for the Six Months Ended June 30, 2019 and Provide Corporate Update on September 3, 2019
finance.yahoo.com - August 20 at 8:10 AM |
| Week In Review: Chipscreen Gains 367% Following $148 Million Shanghai STAR IPO
seekingalpha.com - August 18 at 5:08 PM |
| Zai Lab up 7% accelerated review status for Optune in China
seekingalpha.com - August 13 at 6:15 PM |
| Zai Lab, Recent GIST Hype And HER2 Turmoil Revealed An Excellent Short-Selling Opportunity
seekingalpha.com - July 5 at 5:04 PM |
| Here is What Hedge Funds Think About Zai Lab Limited (ZLAB)
finance.yahoo.com - July 5 at 5:04 PM |
| Incyte teams up with Zai Lab in Greater China
seekingalpha.com - July 2 at 9:49 AM |
| China biotech groups spend billions on overseas drug candidates
finance.yahoo.com - June 24 at 5:44 PM |
| Zai Lab: A Pearl In The Healthcare Market
seekingalpha.com - June 19 at 11:32 AM |
| Zai Lab gets nod in Macau to sell Zejula for ovarian cancer
seekingalpha.com - June 12 at 1:02 PM |
| Zai Lab Announces Approval to Commercialize ZEJULA (Niraparib) in Macau for Patients with Relapsed Ovarian Cancer
finance.yahoo.com - June 12 at 1:02 PM |
